Aarti Net Receivables vs Long Term Debt Analysis

AARTIDRUGS

386.75 24.75 6.01%

Aarti Drugs financial indicator trend analysis is way more than just evaluating Aarti Drugs Limited prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Aarti Drugs Limited is a good investment. Please check the relationship between Aarti Drugs Net Receivables and its Long Term Debt accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aarti Drugs Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

Net Receivables vs Long Term Debt

Net Receivables vs Long Term Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Aarti Drugs Limited Net Receivables account and Long Term Debt. At this time, the significance of the direction appears to have strong relationship.

The correlation between Aarti Drugs' Net Receivables and Long Term Debt is 0.67. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Long Term Debt in the same time period over historical financial statements of Aarti Drugs Limited, assuming nothing else is changed. The correlation between historical values of Aarti Drugs' Net Receivables and Long Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of Aarti Drugs Limited are associated (or correlated) with its Long Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Long Term Debt has no effect on the direction of Net Receivables i.e., Aarti Drugs' Net Receivables and Long Term Debt go up and down completely randomly.

Correlation Coefficient

0.67

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Net Receivables

Long Term Debt

Long-term debt is a debt that Aarti Drugs Limited has held for over one year. Long-term debt appears on Aarti Drugs Limited balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Aarti Drugs Limited balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Most indicators from Aarti Drugs' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Aarti Drugs Limited current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aarti Drugs Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

As of 02/18/2025, Selling General Administrative is likely to grow to about 171.3 M, while Tax Provision is likely to drop slightly above 566.4 M.

	2022	2023	2024	2025 (projected)
Interest Expense	332.9M	378.9M	435.7M	315.0M
Depreciation And Amortization	503.2M	514.5M	591.6M	367.1M

Interest Expense Depreciation And Amortization

Aarti Drugs fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Accounts Payable	Current Deferred Revenue	Retained Earnings	Other Assets	Short Term Debt	Intangible Assets
Total Assets		0.71	0.11	0.79	0.99	0.98	0.7	0.51	0.98	0.01	0.63	0.83	-0.78	0.7	0.98	-0.04	-0.1	0.83	0.99	0.93	0.88	0.06	0.99	0.17	0.53	0.57
Short Long Term Debt Total	0.71		-0.15	0.88	0.63	0.71	1.0	0.31	0.71	0.02	0.48	0.78	-0.29	0.73	0.66	-0.08	-0.03	0.91	0.7	0.55	0.79	0.12	0.62	0.29	0.72	0.23
Other Current Liab	0.11	-0.15		-0.08	0.16	0.15	-0.14	-0.33	0.15	-0.18	-0.13	0.09	-0.17	0.3	0.09	-0.15	-0.29	0.03	0.08	0.09	0.12	-0.32	0.19	0.11	-0.42	0.25
Total Current Liabilities	0.79	0.88	-0.08		0.74	0.71	0.87	0.6	0.72	-0.03	0.73	0.95	-0.28	0.61	0.81	0.01	-0.11	0.97	0.82	0.7	0.94	0.25	0.71	0.29	0.65	0.12
Total Stockholder Equity	0.99	0.63	0.16	0.74		0.97	0.62	0.52	0.97	0.06	0.64	0.81	-0.81	0.66	0.98	0.0	-0.06	0.78	0.98	0.96	0.87	0.0	1.0	0.16	0.47	0.63
Property Plant And Equipment Net	0.98	0.71	0.15	0.71	0.97		0.71	0.37	1.0	0.0	0.48	0.75	-0.82	0.75	0.94	-0.07	-0.1	0.79	0.94	0.88	0.82	-0.01	0.97	0.11	0.46	0.67
Net Debt	0.7	1.0	-0.14	0.87	0.62	0.71		0.27	0.7	0.01	0.45	0.76	-0.28	0.73	0.65	-0.08	-0.02	0.9	0.68	0.53	0.77	0.1	0.61	0.29	0.71	0.23
Cash	0.51	0.31	-0.33	0.6	0.52	0.37	0.27		0.38	0.07	0.86	0.64	-0.25	0.18	0.62	-0.09	-0.03	0.53	0.6	0.61	0.65	0.54	0.5	0.03	0.49	-0.03
Non Current Assets Total	0.98	0.71	0.15	0.72	0.97	1.0	0.7	0.38		0.01	0.49	0.75	-0.83	0.74	0.94	-0.05	-0.1	0.78	0.94	0.88	0.82	-0.01	0.97	0.1	0.47	0.68
Non Currrent Assets Other	0.01	0.02	-0.18	-0.03	0.06	0.0	0.01	0.07	0.01		0.13	-0.14	-0.06	-0.29	0.05	0.28	0.93	-0.11	0.02	0.24	-0.03	-0.52	0.04	0.17	0.4	0.21
Cash And Short Term Investments	0.63	0.48	-0.13	0.73	0.64	0.48	0.45	0.86	0.49	0.13		0.8	-0.28	0.29	0.72	-0.04	0.0	0.66	0.72	0.71	0.78	0.34	0.61	0.42	0.66	0.0
Net Receivables	0.83	0.78	0.09	0.95	0.81	0.75	0.76	0.64	0.75	-0.14	0.8		-0.37	0.68	0.85	-0.02	-0.24	0.95	0.87	0.77	0.98	0.24	0.79	0.32	0.53	0.19
Common Stock Shares Outstanding	-0.78	-0.29	-0.17	-0.28	-0.81	-0.82	-0.28	-0.25	-0.83	-0.06	-0.28	-0.37		-0.48	-0.74	0.01	0.06	-0.36	-0.73	-0.73	-0.47	0.07	-0.83	0.11	-0.27	-0.79
Non Current Liabilities Total	0.7	0.73	0.3	0.61	0.66	0.75	0.73	0.18	0.74	-0.29	0.29	0.68	-0.48		0.65	-0.35	-0.33	0.78	0.65	0.55	0.72	0.09	0.69	0.13	0.26	0.39
Inventory	0.98	0.66	0.09	0.81	0.98	0.94	0.65	0.62	0.94	0.05	0.72	0.85	-0.74	0.65		-0.02	-0.07	0.83	0.99	0.95	0.91	0.11	0.97	0.19	0.53	0.49
Other Current Assets	-0.04	-0.08	-0.15	0.01	0.0	-0.07	-0.08	-0.09	-0.05	0.28	-0.04	-0.02	0.01	-0.35	-0.02		0.32	-0.09	-0.03	0.01	-0.04	-0.11	-0.01	-0.14	-0.05	0.26
Other Stockholder Equity	-0.1	-0.03	-0.29	-0.11	-0.06	-0.1	-0.02	-0.03	-0.1	0.93	0.0	-0.24	0.06	-0.33	-0.07	0.32		-0.19	-0.1	0.11	-0.14	-0.46	-0.09	0.22	0.29	0.11
Total Liab	0.83	0.91	0.03	0.97	0.78	0.79	0.9	0.53	0.78	-0.11	0.66	0.95	-0.36	0.78	0.83	-0.09	-0.19		0.84	0.71	0.96	0.22	0.77	0.27	0.6	0.21
Total Current Assets	0.99	0.7	0.08	0.82	0.98	0.94	0.68	0.6	0.94	0.02	0.72	0.87	-0.73	0.65	0.99	-0.03	-0.1	0.84		0.94	0.91	0.11	0.97	0.22	0.56	0.48
Common Stock	0.93	0.55	0.09	0.7	0.96	0.88	0.53	0.61	0.88	0.24	0.71	0.77	-0.73	0.55	0.95	0.01	0.11	0.71	0.94		0.83	-0.08	0.94	0.22	0.48	0.54
Accounts Payable	0.88	0.79	0.12	0.94	0.87	0.82	0.77	0.65	0.82	-0.03	0.78	0.98	-0.47	0.72	0.91	-0.04	-0.14	0.96	0.91	0.83		0.21	0.85	0.26	0.56	0.3
Current Deferred Revenue	0.06	0.12	-0.32	0.25	0.0	-0.01	0.1	0.54	-0.01	-0.52	0.34	0.24	0.07	0.09	0.11	-0.11	-0.46	0.22	0.11	-0.08	0.21		0.01	-0.23	0.14	-0.25
Retained Earnings	0.99	0.62	0.19	0.71	1.0	0.97	0.61	0.5	0.97	0.04	0.61	0.79	-0.83	0.69	0.97	-0.01	-0.09	0.77	0.97	0.94	0.85	0.01		0.13	0.45	0.66
Other Assets	0.17	0.29	0.11	0.29	0.16	0.11	0.29	0.03	0.1	0.17	0.42	0.32	0.11	0.13	0.19	-0.14	0.22	0.27	0.22	0.22	0.26	-0.23	0.13		0.32	-0.32
Short Term Debt	0.53	0.72	-0.42	0.65	0.47	0.46	0.71	0.49	0.47	0.4	0.66	0.53	-0.27	0.26	0.53	-0.05	0.29	0.6	0.56	0.48	0.56	0.14	0.45	0.32		0.1
Intangible Assets	0.57	0.23	0.25	0.12	0.63	0.67	0.23	-0.03	0.68	0.21	0.0	0.19	-0.79	0.39	0.49	0.26	0.11	0.21	0.48	0.54	0.3	-0.25	0.66	-0.32	0.1

Click cells to compare fundamentals

Aarti Drugs Account Relationship Matchups

Aarti Drugs fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	17.7B	22.1B	24.2B	24.3B	28.0B	29.4B
Short Long Term Debt Total	3.5B	5.4B	6.1B	5.6B	6.5B	4.3B
Other Current Liab	521.7M	(435M)	445.2M	567.2M	510.5M	255.7M
Total Current Liabilities	6.0B	9.4B	9.3B	8.0B	9.1B	5.0B
Total Stockholder Equity	9.1B	10.4B	11.9B	12.8B	14.7B	15.5B
Property Plant And Equipment Net	6.8B	7.7B	8.9B	10.5B	12.1B	12.7B
Net Debt	3.4B	5.2B	6.0B	5.6B	6.4B	4.2B
Cash	88.1M	216.1M	89.6M	67.4M	77.5M	65.7M
Non Current Assets Total	7.1B	8.1B	9.3B	11.1B	12.8B	13.4B
Non Currrent Assets Other	72.6M	284.4M	236.7M	9.0M	8.1M	8.5M
Cash And Short Term Investments	88.1M	216.1M	211.7M	89.3M	102.7M	74.5M
Net Receivables	5.6B	7.6B	8.6B	7.0B	8.1B	4.1B
Liabilities And Stockholders Equity	17.7B	22.1B	24.2B	24.3B	28.0B	29.4B
Non Current Liabilities Total	2.6B	2.3B	3.0B	3.5B	4.1B	2.6B
Inventory	4.2B	5.3B	5.2B	4.9B	5.6B	5.9B
Other Current Assets	645.8M	825.6M	900.5M	1.2B	1.4B	863.3M
Other Stockholder Equity	664.3M	650.1M	(47.0K)	15K	13.5K	14.2K
Total Liab	8.5B	11.7B	12.3B	11.5B	13.2B	7.6B
Total Current Assets	10.6B	13.9B	14.9B	13.2B	15.2B	15.9B
Accumulated Other Comprehensive Income	664.3M	650.1M	793.0M	343.7M	395.2M	415.0M
Common Stock	233M	932M	926M	919.4M	1.1B	1.1B
Accounts Payable	3.3B	4.7B	4.8B	4.5B	5.2B	2.8B
Current Deferred Revenue	(396.1M)	1.1B	43.7M	11.8M	13.6M	12.9M
Retained Earnings	7.5B	8.8B	10.2B	11.6B	13.3B	13.9B
Other Assets	11.5M	1K	72.6M	236.7M	1.15	1.09
Short Term Debt	2.0B	4.0B	4.0B	2.9B	3.3B	3.1B
Intangible Assets	2.6M	1.5M	7.9M	368.2M	423.5M	444.7M
Short Term Investments	127.2M	126.4M	122.1M	21.9M	25.1M	23.9M
Other Liab	1.1B	1.1B	912.2M	906.7M	1.0B	949.0M
Net Tangible Assets	6.5B	9.1B	10.4B	11.9B	13.7B	14.4B
Long Term Debt	1.5B	1.4B	2.0B	2.8B	3.2B	2.0B
Short Long Term Debt	1.6B	4.0B	4.0B	2.9B	3.3B	2.8B
Property Plant Equipment	6.5B	6.8B	7.7B	8.9B	10.2B	6.8B
Long Term Debt Total	1.9B	1.5B	1.4B	2.1B	1.8B	1.5B
Non Current Liabilities Other	(32K)	(3K)	(33K)	(58K)	(52.2K)	(49.6K)
Net Invested Capital	12.2B	15.7B	18.0B	18.4B	21.2B	15.0B
Net Working Capital	4.6B	4.5B	5.6B	5.3B	6.0B	4.1B
Capital Stock	233M	932M	926M	919.4M	1.1B	764.9M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CSX	CSX Corporation
ETON	Eton Pharmaceuticals
ALLT	Allot Communications

Additional Tools for Aarti Stock Analysis

When running Aarti Drugs' price analysis, check to measure Aarti Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aarti Drugs is operating at the current time. Most of Aarti Drugs' value examination focuses on studying past and present price action to predict the probability of Aarti Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aarti Drugs' price. Additionally, you may evaluate how the addition of Aarti Drugs to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Aarti Net Receivables vs Long Term Debt Analysis

Net Receivables vs Long Term Debt

Net Receivables vs Long Term Debt Correlation Analysis

Correlation Coefficient

Net Receivables

Long Term Debt

Aarti Drugs fundamental ratios Correlations

Aarti Drugs Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Aarti Drugs fundamental ratios Accounts

Also Currently Popular

Additional Tools for Aarti Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Debt	+ 1.0	Short Long Term Debt Total
Retained Earnings	+ 1.0	Total Stockholder Equity
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Total Stockholder Equity	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Assets
Retained Earnings	+ 0.99	Total Assets

Retained Earnings	- 0.83	Common Stock Shares Outstanding
Common Stock Shares Outstanding	- 0.83	Non Current Assets Total
Common Stock Shares Outstanding	- 0.82	Property Plant And Equipment Net
Common Stock Shares Outstanding	- 0.81	Total Stockholder Equity
Intangible Assets	- 0.79	Common Stock Shares Outstanding
Common Stock Shares Outstanding	- 0.78	Total Assets